The article A Deeper Look at Ketamine and its Potential for Addiction was originally published on Microdose. Ketamine might be the current poster child...
A prolific SPAC creator has found a business partner for its fifth blank check company with just four weeks to go before a business combination deadline....
The article Small Pharma Expands IP With Another US Patent was originally published on Microdose. With the recent focus (and fuss) around patent protection...
The article Top 5 Psychedelic Clinical Trials in 2022 was originally published on Microdose. In order for psychedelic medicines to be legalized in a doctor-prescribed...
The article Can LSD Make You Smarter? New Study Shows Positive Results was originally published on Microdose. Humans are always on the hunt for life hacks,...
Silo Pharma (NASDAQ: SILO) shares are catching a bid, moving 16% higher to reach $6.39 on Tuesday. The move isn’t surprising; SILO is attracting the...
Mental health professionals turn to ketamine for treatment-resistant conditions. The post Ketamine Use Case Expands, But Concerns Persist appeared first...
Empyrean Neuroscience, Inc., a genetic engineering company dedicated to developing neuroactive compounds to treat neuropsychiatric and neurologic disorders,...
The article Top Reasons To Be At Wonderland 2022 (Part 1) was originally published on Microdose. 2021 was a big year for the psychedelic medicine industry....
Core One Labs Inc. (CSE: COOL | OTC: CLABF | Frankfurt: LD6, WKN: A3CSSU), further to its press release dated August 18, 2022, is excited to announce...